Applied NeuroSolutions, Inc. (OTC BB: APNS) is developing products to diagnose and treat Alzheimer's disease based on a novel hypothesis of AD pathology. In partnership with Dr. Peter Davies and a scientific team at Albert Einstein College of Medicine, Applied NeuroSolutions has developed a cerebrospinal fluid (CSF) test to detect Alzheimer's disease at a very early stage with 85%-95% accuracy in more than 3,000 patient samples. There are approximately 2 million new patients annually worldwide who are candidates for an AD CSF diagnostic test, according to Datamonitor. The company is also developing a blood serum-based screening test, as well as a new class of therapeutics to treat AD. Alzheimer's disease currently afflicts over 4 million Americans, and the market for AD therapy is expected to grow to 21 million patients by 2010 in the seven major pharmaceutical markets (USA, France, Germany, Italy, Spain, U.K. and Japan) according to BioPortfolio, Ltd. There are currently no FDAapproved diagnostic tests to detect Alzheimer's disease.
View Top Employees from Cr-Neurosolutions,Inc.Website | http://www.appliedneurosolutions.com |
Revenue | $9 million |
Employees | View employees |
Address | 50 Lakeview Pkwy, Ste 111, Vernon Hills, Illinois 60061, US |
Phone | (847) 573-8000 |
Fax | (847) 573-8030 |
Industry | Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
SIC | SIC Code 73 Companies, SIC Code 738 Companies |
NAICS | NAICS Code 56 Companies, NAICS Code 561 Companies |
Looking for a particular Cr-Neurosolutions,Inc. employee's phone or email?
The Cr-Neurosolutions,Inc. annual revenue was $9 million in 2024.
Cr-Neurosolutions,Inc. is based in Vernon Hills, Illinois.
The NAICS codes for Cr-Neurosolutions,Inc. are [56, 561].
The SIC codes for Cr-Neurosolutions,Inc. are [73, 738].